Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: A systematic literature review

Clinical Rheumatology

Volumn 31, Issue 5, 2012, Pages 801-806

  Wang, Dong Xue ^a   Shu, Xiao Ming ^a   Tian, Xiao Lan ^a   Chen, Fang ^a   Zu, Ning ^a   Ma, Li ^a   Wang, Guo Chun ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Dermatomyositis; Intravenous immunoglobulin; Polymyositis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHILL; CORTICOSTEROID THERAPY; CREATINE KINASE BLOOD LEVEL; DELIRIUM; DERMATOMYOSITIS; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FEVER; HEADACHE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LIVER DISEASE; MEDICAL LITERATURE; MYALGIA; NAUSEA; POLYMYOSITIS; PRIORITY JOURNAL; RASH; SEPSIS; SIDE EFFECT; STROKE; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

DATABASES, BIBLIOGRAPHIC; DERMATOMYOSITIS; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; POLYMYOSITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84863720805     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-1940-5     Document Type: Article

References (23)

1. Roifman CM, Schaffer FM, Wachsmuth SE, Murphy G, Gelfand EW (1987) Reversal of chronic polymyositis following intravenous immune serum globulin therapy. JAMA 258:513-515
2. Phillips B, Ball C, Sacker D, Badenoch D, Straus S, Haynes B, Dawes M (2009) Oxford Centre for Evidence-based Medicine Levels of Evidence (March). http://www.cebm.net/index.aspx? o01025. Accessed 11 Oct 2011
3. Suzuki Y, Hayakawa H, Miwa S, Shirai M, Fujii M, Gemma H, Suda T, Chida K (2009) Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis. Lung 187:201-206
4. Marie I, Menard JF, Hatron PY, Hachulla E, Mouthon L, Tiev K, Ducrotte P, Cherin P (2010) Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res 62:1748-1755
5. Tian J, Gao JS, Chen JW, Li F, Xie X, Du JF (2008) Efficacy and safety of the combined treatment with intravenous immunoglobulin and oral glucocorticoid in the elderly with dermatomyositis. Chin J Geriatr 27:588-590
6. Cherin P, Piette JC, Wechsler B, Bletry O, Ziza JM, Laraki R, Godeau P, Herson S (1994) Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. J Rheumatol 21:1092-1097
7. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, Dinsmore ST, McCrosky S (1993) A controlled trial of highdose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993-2000
8. Danieli MG, Calcabrini L, Calabrese V, Marchetti A, Logullo F, Gabrielli A (2009) Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. Autoimmun Rev 9:124-127
9. Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S (2002) Results and long-term follow-up of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 46:467-474
10. Danieli MG, Malcangi G, Palmieri C, Logullo F, Salvi A, Piani M, Danieli G (2002) Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. Ann Rheum Dis 61:37-41
11. Saito E, Koike T, Hashimoto H, Miyasaka N, Ikeda Y, Hara M, Yamada H, Yoshida T, Harigai M, Ichikawa Y (2008) Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis. Mod Rheumatol 18:34-44
12. Quick A, Tandan R (2011) Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease. Curr Rheumatol Rep 13:192-198
13. Chung L, Genovese MC, Fiorentino DF (2007) A pilot trial of rituximab in the treatment of patients with dermatomyositis. Arch Dermatol 143:763-767
14. Dalakas MC (2011) Immunotherapy of inflammatory myopathies: practical approach and future prospects. Curr Treat Options Neurol 13:311-323
15. Mastaglia FL, Phillips BA, Zilko PJ (1998) Immunoglobulin therapy in inflammatory myopathies. J Neurol Neurosurg Psychiatry 65:107-110
16. Wittstock M, Benecke R, Zettl UK (2003) Therapy with intravenous immunoglobulins: complications and side-effects. Eur Neurol 50:172-175
17. Nozaki Y, Ikoma S, Funauchi M, Kinoshita K (2008) Respiratory muscle weakness with dermatomyositis during pregnancy: successful treatment with intravenous immunoglobulin therapy. J Rheumatol 35:2289
18. Williams L, Chang PY, Park E, Gorson KC, Bayer-Zwirello L (2007) Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy. Obstet Gynecol 109:561-563
19. Mosca M, Strigini F, Carmignani A, D'ascanio A, Genazzani AR, Bombardieri S (2005) Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy. Arthritis Rheum 53:119-121
20. Cherin P, Herson S, Wechsler B, Piette JC, Bletry O, Coutellier A, Ziza JM, Godeau P (1991) Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med 91:162-168
21. Göttfried I, Seeber A, Anegg B, Rieger A, Stingl G, Volc-Platzer B (2000) High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels. Eur J Dermatol 10:29-35
22. Kamali S, Cefle A, Sayarlioglu M, Gul A, Inanc M, Ocal L, Konice OAM (2005) Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases. Rheumatol Int 25:211-214
23. Helmers SB, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B, Lundberg IE (2007) Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann Rheum Dis 66:1276-1283